Could a structured nursing program boost quality of life in advanced lung cancer?

NCT ID NCT07679165

Completed Symptom relief Sponsor: Jie Zeng Source: ClinicalTrials.gov ↗

First seen Jul 01, 2026 · Last updated Jul 02, 2026 · Updated 1 time

Summary

This trial investigates whether an 8-week systematic symptom management nursing program can improve quality of life, self-management skills, and psychological resilience in people with advanced (stage IIIB–IV) lung cancer. Participants are randomly assigned to receive either routine care or the structured program. The study measures changes in quality of life, self-management efficacy, and other outcomes using validated questionnaires.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: standardized systematic symptom management nursing intervention
What this could lead to: If effective, this nursing program could become a standard way to help advanced lung cancer patients feel better and manage their own care more confidently.
What could go wrong: This is a single-center study with a modest sample size, so results may not apply broadly. The intervention is behavioral, so benefits may vary from person to person.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LATE STAGE LUNG CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

lung cancer lung carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

LATE STAGE LUNG CANCER MEDIATING EFFECT PSYCHOLOGICAL RESILIENCE QOL SELF MANAGEMENT EFFICACY SYMPTOM MANAGEMEN

Contacts and locations

Locations

Dahua Hospital, Xuhui District, Shanghai

Shanghai, Shanghai Municipality, 200031, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.